Tissue-targeting lead generation and optimization from random and directed screening of technetium-99m labeled tripeptide complex libraries in vivo

( views:104, downloads:0 )
ZENG Jun()
LIU Ci-yi()
XIE Wen-hui()
HU Si-long()
JIN Mu-xiu()
Journal Title:
Volume 119, Issue 17, 2006
Key Word:
99mTc labeled;tripeptide libraries;in vivo;random screening;directed screening

Abstract: Background Screening libraries against a molecular target in vitro are idealized models that cannot reflect the real state in vivo where biomolecules coexist and interact. C-terminal amide tripeptides labelled with Technetium-99m can provide a unique noninvasive approach to trace a large number of compounds in vivo.Methods The C-terminal amide tripeptide libraries were synthesized on Rink Amide-MBHA resin using iterative and pooling protocol. Technetium (Ⅴ) oxo core [TcO3+] was bound to each tripeptide via 4 deprotonated nitrogen atoms to form a library of 8000 99mTc tripeptoid complexes. The radiocombinatorial screening (RCS) in vivo was carried out on SD rats and A549 tumour bearing mice.Results Signals of tissue distribution and metabolism of libraries were recorded by counting or imaging and tissue targeting leads identified by both random and directed RCS. Among them, 99mTc RPA, 99mTc VIG and 99mTc RES had specific tissue targeting in kidney, liver and tumour respectively. The percent injected dose per gram tissue of 99mTc labelled leads in their target tissue was highly structure dependent. Because the nontarget tissue binding and the metabolism of 99mTc tripeptoid sublibraries were simultaneously monitored successfully by RCS, the interference of background activity was limited to the lowest level. Optimization of renal function agent from the labelled libraries was carried out by directed screening. 99mTc DSG was finally identified the most promising agent for renal function studies.Conclusions RCS in vivo is a powerful tool for the discovery of tissue targeting drugs. The potential screening bias is probably the major limitation of labelled libraries.

  • [1]Scott JK,Smith GP.Searching for peptide ligands with an epitope library.Science 1990;249:386-390.
  • [2]Lam KS,Salmon SE,Hersh EM,Hruby VJ,Kazmierski WM,Knapp RJ.A new type of synthetic peptide library for identifying ligand-binding activity.Nature 1991 ;354:82-84.
  • [3]Houghten RA,Pinilla C,Blondelle SE,Appel JR,Dooley CT,Cuervo JH.Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery.Nature 1991 ;354:84-86.
  • [4]Devlin JJ,Panganiban LC,Devlin PE.Random peptide libraries:a source of specific protein binding molecules.Science 1990;249:404-406.
  • [5]Irving MB,Pan O,Scott JK.Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics.Curr Opin Chem Biol 2001; 5:314-324.
  • [6]Golebiowski A,Klopfenstein SR,Portlock,DE.Lead compounds discovered from libraries:part 2.Curr Opin Chem Biol 2003;7:308-325.
  • [7]Sehgal A.Recent developments in peptide-based cancer therapeutics.Curr Opin Drug Discov Devel 2002;5:245-250.
  • [8]Gordon EM,Barrett RW,Dower WJ,Fodor SP,Gallop MA.Applications of combinatorial technologies to drug discovery.1.Background and peptide combinatorial libraries.J Med Chem 1994; 37:1233-1251.
  • [9]Bunin BA,Plunkett MJ,Ellman JA.The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library.Proc Natl Acad Sci USA 1994;91:4708-4712.
  • [10]Wood WJ,Huang L,Ellman JA.Synthesis of a diverse library of mechanism-based cysteine protease inhibitors.J Comb Chem 2003;5:869-880.
  • [11]Thompson LA,Ellman JA.Synthesis and applications of small molecule libraries.Chem Rev 1996;96:555-600.
  • [12]Port RE,Wolf W.Noninvasive methods to study drug distribution.Invest New Drugs 2003;21:157-168.
  • [13]Pinilla C,Appel JR,Blondelle SE,Dooley CT,Eichler J,Ostresh M,et al.Versatility of positional scaning synthetic combinatorial libraries for the identification of individual compounds.Drug Dev Res 1994;33:133-145.
  • [14]Fields GB,Noble RL.Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl aminoacids.In J Peptide Protein Res 1990;35:161-214.
  • [15]Boussard C,Doyle VE,Mahmood N,Klimkait T,Pritchard M,Gilbert IH.Design,synthesis and evaluation of peptide libraries as potential anti-HIV compounds,via inhibition of gp120/cell membrane interactions,using the gp120/cd4/fab17 crystal structure.Eur J Med Chem 2002;37:883-890.
  • [16]Vanbilloen HP,Bormans GM,DE Roo MJ,Verbruggen AM.Complexes of technetium-99m with tetrapeptides,a new class of 99mTc labelled agents.Nucl Med Biol 1995;22:325-338.
  • [17]Gordon EM.Strategies in the design and synthesis of chemical libraries.In:Gordon EM,Kerwin JF Jr,editors.Combinatorial Chemistry and Molecular diversity in Drug Discovery.New York:John Wiley and Sons;1998:17-38.
  • [18]Moos WH,Green GD,Pavia MR.Recent advance in the generation of molecular diversity.Annu Rep Med Chem 1993;28:315-324.
  • [19]Otto S,Furlan RL,Sanders JK.Dynamic combinatorial chemistry.Drug Discov Today 2002;7:117-125.
  • [20]Chatziioannou AF.Molecular imaging of small animals with dedicated PET tomographs.Eur J Nucl Med Mol Imaging 2002;29:98-114.
  • [21]Wust F.Use of[99mTc]technetium-labeled steroids as probes for steroid hormone receptors.Methods Mol Biol 2001;176:133-143.
  • [22]Virgolini I,Traub T,Novotny C,et al.New trends in peptide receptor radioligands.Q J Nucl Med 2001;45:153-159.
  • [23]Kwekkeboom D,Krenning EP,de Jong M.Peptide receptor imaging and therapy.J Nucl Med 2000;41:1704-1713.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn